Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate impacts of an emotion recognition rehabilitation program, named Training of Affect Recognition, on social cognition abilities in Alzheimer's disease (AD). In addition, we hypothesis that the effect of this rehabilitation will also evolve gaze strategies, behavioral disorders, and the caregiver's burden.


Clinical Trial Description

It is commonly admitted that social cognition impairment, like deficit in facial emotion recognition or misinterpretation of others' intentions (Theory of Mind), are associated with social behavior disorders. This kind of disorders are observed in Fronto-Temporal Dementia, Alzheimer's Dementia (AD) and Parkinson's Disease, with severe deficits in FTD and lighter deficits in AD and PD. One explanation is that patients apply inappropriate visual exploration strategies to decode emotions and intentions of others. Our study aims to evaluate impacts of an emotion recognition rehabilitation program, named Training of Affect Recognition, on social cognition abilities (facial emotion recognition (FER) and theory of mind (ToM)) in Alzheimer's disease (AD). In addition, we hypothesis that the effect of this rehabilitation will also evolve gaze strategies, behavioral disorders, and the caregiver's burden. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04730440
Study type Observational
Source Centre Hospitalier Princesse Grace
Contact
Status Completed
Phase
Start date March 1, 2019
Completion date March 26, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03255720 - Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes N/A
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A
Withdrawn NCT05497817 - A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia N/A
Completed NCT02317523 - Alzheimer's Caregiver Coping: Mental and Physical Health N/A
Completed NCT03538522 - A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 Phase 2
Terminated NCT03132272 - Immunoadsorption for Treatment of Alzheimer's Disease N/A
Recruiting NCT03275363 - The University of Hong Kong Neurocognitive Disorder Cohort N/A
Enrolling by invitation NCT03724136 - Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study N/A
Completed NCT02267486 - Exploratory Study for the Validity of QuQu Scale N/A
Active, not recruiting NCT03748303 - Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study Phase 1
Completed NCT03611439 - Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients N/A
Completed NCT04058886 - Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers N/A
Recruiting NCT03584568 - Reappraising Intergeneration Relationships in Dementia Caregiving N/A
Not yet recruiting NCT05113732 - Association of Cognition With Functional Mobility in People With Alzheimer's Disease
Completed NCT03811847 - A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants. Phase 4
Terminated NCT03044249 - A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression Phase 2
Active, not recruiting NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) N/A
Completed NCT03718494 - Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
Completed NCT03602391 - The Senior Companion Program Plus N/A
Completed NCT03548584 - A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type Phase 3